The Role of Genetic Insights in Choosing Your Next GLP-1 The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
"Quillivant XR methylphenidate hydrochloride suspension, extended release"
For patients seeking additional peptide synergy, PlexusDx provides Compounded Tirzepatide Injection (at $289/mo month-to-month, or from $249/mo on the 6-month plan)a dual GLP-1/GIP receptor agonist that may produce superior weight loss compared to semaglutide alone, based on the SURMOUNT clinical trials
Watch our video to learn how to properly collect and handle GLP-1 samples for more accurate results
Ethics approval was not sought for this analysis given the data are publicly available
It is anticipated that, with the design and/or discovery of novel producers, the biotechnological production of glutathione will be further improved to expand the application range of this physiologically and medically important tripeptide